Medtech PIPE Volume, Share Gains Indicate Rebound In Private Investments
A new analysis of medtech PIPE deals in Informa’s Strategic Transactions and PlacementTracker shows a rebound in transaction and dollar volume.
You may also be interested in...
Device start-ups raised $1.7 billion in 2013, and approximately 75% of the total was from Series C or later rounds, a sign that investors are still more comfortable making investments in more advanced companies.
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.